Clinical Trial Update: Neoadjuvant Immunoradiotherapy in Head & Neck Cancer [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update describes a Phase 1/2 neoadjuvant immunoradiotherapy study for head and neck cancer, currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer
• Head and Neck Squamous Cell Carcinoma

Snippet

Sponsor: Providence Health & Services | Conditions: Head and Neck Cancer, Head and Neck Squamous Cell Carcinoma | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING